NFKB1 and diabetic kidney disease: Activation of anti-oxidant responses via Nrf2 and inhibition of NF-kB by the triterpenoid bardoxolone methyl reduces oxidative stress, inflammation and promotes mitochondrial function in numerous experimental models of CKD, including DKD (Pergola et al., 2011).